I like the idea of having forward guidance. Getting revenue projections should be part of the companies plan at some point. Seems like the VA system block of business would be a reasonable place to start. I haven't seen anything on the drug cost yet or expected treatment reimbursement.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links